Welcome to the Doctors' Portal
00:00 Sunday
Mediclinic News : Aspen signs off on GSK drug transaction

Title

Aspen signs off on GSK drug transaction

Date

2017-03-01

Link

News Description

FIN24.COM Cape Town - South Africa's biggest generic drug maker Aspen Pharmacare [JSE:APN] signed off on an agreement with GlaxoSmithKline to acquire a portfolio of anaesthetics, the company reported on Wednesday. The company will pay an initial amount of £180m, paying an added £100m if certain goals are met in the three years following completion, according to a statement issued on Wednesday. The transaction was completed on February 28 2017 on a global scale and on a national scale in Durban on March 1 2017. The deal adds to the anaesthetics Aspen bought in June from AstraZeneca of the UK for as much as $770m. Aspen's shares declined 0.21% to R282.78 as of 16:32 on the Johannesburg Stock Exchange.
Created at 2017/03/08 04:26 PM by Mediclinic
Last modified at 2017/03/08 04:26 PM by Mediclinic